SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wahren Herlenius Marie)
 

Sökning: WFRF:(Wahren Herlenius Marie) > Type I interferon p...

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases : a systematic literature review informing EULAR points to consider

Burska, Agata (författare)
Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England.;NIHR Leeds Biomed Res Ctr, Leeds, England.
Rodriguez-Carrio, Javier (författare)
Univ Oviedo, Area Immunol, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain.
Biesen, Robert (författare)
Charite Univ Med Berlin, Dept Rheumatol, Berlin, Germany.
visa fler...
Dik, Willem A. (författare)
Univ Med Ctr Rotterdam, Erasmus MC, Dept Immunol, Lab Med Immunol,Netherlands Immunol, Rotterdam, Netherlands.
Eloranta, Maija-Leena (författare)
Uppsala universitet,Reumatologi
Cavalli, Giulio (författare)
Univ Vita Salute San Raffaele, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy.;EULAR, PARE Patient Res Partners, Amsterdam, Netherlands.
Visser, Marianne (författare)
Univ Crete, Med Sch, Dept Internal Med, Iraklion, Greece.
Boumpas, Dimitrios T. (författare)
Univ Crete, Med Sch, Dept Rheumatol Clin Immunol, Iraklion, Greece.
Bertsias, George (författare)
Univ Crete, Med Sch, Dept Rheumatol Clin Immunol, Iraklion, Greece.
Wahren-Herlenius, Marie (författare)
Karolinska Institutet
Rehwinkel, Jan (författare)
Univ Oxford, Med Res Council Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Radcliffe Dept Med, Oxford, England.
Fremond, Marie-Louise (författare)
Crow, Mary K. (författare)
Hosp Special Surg, Weill Cornell Med Coll, Mary Kirkland Ctr Lupus Res, New York, NY USA.
Rönnblom, Lars (författare)
Uppsala universitet,Reumatologi
Conaghan, P. G. (författare)
Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England.;NIHR Leeds Biomed Res Ctr, Leeds, England.
Versnel, Marjan (författare)
Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
Vital, Ed (författare)
Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England.;NIHR Leeds Biomed Res Ctr, Leeds, England.
visa färre...
Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England;NIHR Leeds Biomed Res Ctr, Leeds, England. Univ Oviedo, Area Immunol, Inst Invest Sanitaria Principado Asturias ISPA, Oviedo, Spain. (creator_code:org_t)
2023-03-02
2023
Engelska.
Ingår i: RMD Open. - : BMJ Publishing Group Ltd. - 2056-5933. ; 9:1
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • ObjectivesTo systematically review the literature for assay methods that aim to evaluate type I interferon (IFN-I) pathway activation and to harmonise-related terminology.MethodsThree databases were searched for reports of IFN-I and rheumatic musculoskeletal diseases. Information about the performance metrics of assays measuring IFN-I and measures of truth were extracted and summarised. A EULAR task force panel assessed feasibility and developed consensus terminology.ResultsOf 10 037 abstracts, 276 fulfilled eligibility criteria for data extraction. Some reported more than one technique to measure IFN-I pathway activation. Hence, 276 papers generated data on 412 methods. IFN-I pathway activation was measured using: qPCR (n=121), immunoassays (n=101), microarray (n=69), reporter cell assay (n=38), DNA methylation (n=14), flow cytometry (n=14), cytopathic effect assay (n=11), RNA sequencing (n=9), plaque reduction assay (n=8), Nanostring (n=5), bisulphite sequencing (n=3). Principles of each assay are summarised for content validity. Concurrent validity (correlation with other IFN assays) was presented for n=150/412 assays. Reliability data were variable and provided for 13 assays. Gene expression and immunoassays were considered most feasible. Consensus terminology to define different aspects of IFN-I research and practice was produced.ConclusionsDiverse methods have been reported as IFN-I assays and these differ in what elements or aspects of IFN-I pathway activation they measure and how. No 'gold standard' represents the entirety of the IFN pathway, some may not be specific for IFN-I. Data on reliability or comparing assays were limited, and feasibility is a challenge for many assays. Consensus terminology should improve consistency of reporting.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Nyckelord

Arthritis
Rheumatoid
Cytokines
Inflammation
Lupus Erythematosus
Systemic

Publikations- och innehållstyp

ref (ämneskategori)
for (ämneskategori)

Hitta via bibliotek

  • RMD Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy